Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025 financial guidance announcement
Eli Lilly (NYSE: LLY) has scheduled the announcement of its fourth-quarter 2024 financial results and 2025 financial guidance for February 6, 2025. The company will host a conference call at 10 a.m. Eastern time on the same day to discuss the results with investors, media, and the general public.
A live webcast of the conference call will be accessible through Lilly's investor relations website, with a replay available afterward for those unable to attend the live event.
Eli Lilly (NYSE: LLY) ha programmato l'annuncio dei suoi risultati finanziari del quarto trimestre 2024 e delle previsioni finanziarie per il 2025 per il 6 febbraio 2025. La società ospiterà una chiamata in conferenza alle 10 del mattino, ora dell'Est, lo stesso giorno per discutere i risultati con investitori, media e il pubblico generale.
Una trasmissione in diretta della chiamata in conferenza sarà accessibile attraverso il sito web delle relazioni con gli investitori di Lilly, con una registrazione disponibile successivamente per coloro che non possono partecipare all'evento dal vivo.
Eli Lilly (NYSE: LLY) ha programado el anuncio de sus resultados financieros del cuarto trimestre de 2024 y orientaciones financieras para 2025 para el 6 de febrero de 2025. La compañía llevará a cabo una llamada de conferencia a las 10 a.m., hora del Este, el mismo día para discutir los resultados con inversores, medios de comunicación y el público en general.
Una transmisión en vivo de la llamada de conferencia estará disponible a través del sitio web de relaciones con inversores de Lilly, con una repetición disponible posteriormente para aquellos que no puedan asistir al evento en vivo.
엘리 릴리 (NYSE: LLY)는 2025년 2월 6일에 2024년 4분기 재무 결과와 2025년 재무 전망 발표를 예정하고 있습니다. 회사는 같은 날 동부 표준시 기준 오전 10시에 투자자, 언론 및 일반 대중과 결과에 대해 논의하는 컨퍼런스 콜을 개최할 것입니다.
컨퍼런스 콜의 생중계는 릴리의 투자자 관계 웹사이트를 통해 접근할 수 있으며, 생방송에 참석할 수 없는 분들을 위해 이후에 재방송이 제공될 것입니다.
Eli Lilly (NYSE: LLY) a prévu d'annoncer ses résultats financiers du quatrième trimestre 2024 et les prévisions financières pour 2025 le 6 février 2025. La société organisera un appel conférence à 10 heures, heure de l'Est, le même jour pour discuter des résultats avec des investisseurs, des médias et le grand public.
Une diffusion en direct de l'appel conférence sera accessible via le site web des relations avec les investisseurs de Lilly, avec une rediffusion disponible par la suite pour ceux qui ne peuvent pas assister à l'événement en direct.
Eli Lilly (NYSE: LLY) hat die Ankündigung seiner Finanzergebnisse für das vierte Quartal 2024 und der Finanzprognose für 2025 für den 6. Februar 2025 geplant. Das Unternehmen wird am selben Tag um 10 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse mit Investoren, Medien und der allgemeinen Öffentlichkeit zu besprechen.
Ein Live-Stream der Telefonkonferenz wird über die Investor-Relations-Website von Lilly zugänglich sein, und eine Aufzeichnung wird später für diejenigen zur Verfügung stehen, die nicht an der Live-Veranstaltung teilnehmen können.
- None.
- None.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Refer to: | Carrie Munk; munk_carrie@lilly.com; 317-416-2393 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-fourth-quarter-2024-financial-results-and-2025-financial-guidance-announcement-302358017.html
SOURCE Eli Lilly and Company
FAQ
When will Eli Lilly (LLY) release Q4 2024 earnings?
What time is Eli Lilly's (LLY) Q4 2024 earnings call?
Where can I listen to Eli Lilly's (LLY) Q4 2024 earnings call?
Will Eli Lilly (LLY) provide 2025 guidance with Q4 2024 results?
